Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Heparin Sodium as an HSPG Uptake Probe
2026-09-15
Heparin sodium is more than a benchmark glycosaminoglycan anticoagulant: it can help test whether heparan sulfate proteoglycans regulate nanovesicle uptake. This article connects coagulation assays with a recent Sertoli-cell nanovesicle study while defining the limits of that cross-domain interpretation.
-
Cistanche Nanovesicles Rescue Sertoli-Cell Cell-Cycle Arrest
2026-09-15
This reference study identifies Cistanche deserticola-derived exosome-like nanovesicles as a potential intervention for cyclophosphamide-induced testicular injury. Its central mechanistic finding is that vesicle-delivered miR159b-3p suppresses P21 and restores CDK1-associated cell-cycle progression in Sertoli cells, while human non-obstructive azoospermia data provide translational context.
-
Fluoxetine HCl Workflows for Motivation Research
2026-09-14
Fluoxetine HCl enables a connected workflow spanning serotonin transporter modulation, 5HT2C assays, neuronal plasticity, and reward-related behavior. This guide translates those capabilities into practical concentration planning, developmental-exposure designs, assay comparisons, and troubleshooting strategies for depression research.
-
Fingolimod and In Vivo CAR-T-Mimicking Immunotherapy
2026-09-14
Fingolimod (FTY720) offers a mechanistic framework for studying lymphocyte trafficking, S1P signaling, and neuroimmune resilience alongside emerging in vivo CAR-T-mimicking platforms. This article translates those concepts into practical experimental strategy while distinguishing established evidence from forward-looking combination hypotheses.
-
10058-F4: From Myc Dimerization to TERT Assays
2026-09-13
Explore how 10058-F4, a c-Myc-Max dimerization inhibitor, can function as a mechanistic perturbation tool rather than merely a cytotoxicity reagent. This guide connects TERT chromatin regulation in human pluripotent stem cells with apoptosis assay design, AML research, and prostate cancer models.
-
HotStart Universal 2X Green qPCR Master Mix Guide
2026-09-12
HotStart Universal 2X Green qPCR Master Mix combines hot-start Taq polymerase, Green I dye, and a universal ROX reference dye for dye-based quantitative PCR. It supports real-time PCR gene expression analysis, but melt curve analysis and appropriate controls remain necessary for specificity claims.
-
HyperTrap Heparin HP Column: Applied Workflow
2026-09-11
Turn heparin-binding behavior into a practical enrichment step for coagulation proteins, growth factors, and signaling-protein studies. The HyperTrap Heparin HP Column combines a ready-to-use format, 34 μm particles, and chemically resilient HyperChrom Heparin HP Agarose for reproducible method development.
-
Novel PDK4 Inhibitors: Evidence from Compound 8c
2026-09-11
The reference study used anthraquinone-based medicinal chemistry to identify compound 8c, an allosteric pyruvate dehydrogenase kinase 4 inhibitor with nanomolar biochemical activity and disease-relevant effects in mouse and cellular models. Its findings connect PDK4 inhibition with PDH activation, glucose-tolerance improvement, suppression of allergic responses, and anticancer phenotypes while also highlighting the limitations of translating preclinical data across disease contexts.
-
N-MYC/eIF4G1 Survival Axis in inv(16) AML
2026-09-10
Peramangalam et al. identify N-MYC and its target eIF4G1 as a previously unrecognized survival axis in inv(16) acute myeloid leukemia. By integrating transcriptional, enhancer, cellular, primary-sample, and patient-derived xenograft analyses, the study connects CBFβ-SMMHC activity with a leukemic gene-expression program that may be therapeutically exploitable.
-
AI-10-49 Workflow for inv(16) AML Research
2026-09-10
AI-10-49 enables mechanism-led acute myeloid leukemia research by disrupting the CBFβ-SMMHC–RUNX1 interaction and restoring RUNX1-associated transcriptional readouts. This workflow connects target engagement, chromatin immunoprecipitation, MYCN/eIF4G1 pathway analysis, cell survival assays, and carefully controlled in vivo validation.
-
Cistanche Nanovesicles Protect Sertoli Cells
2026-09-09
A 2025 preprint reports that Cistanche deserticola-derived exosome-like nanovesicles alleviate cyclophosphamide-induced testicular injury by targeting Sertoli-cell cycle arrest. The proposed mechanism links heparan sulfate proteoglycan-mediated uptake with delivery of miR159b-3p, suppression of P21, and phosphorylation-dependent CDK1 activation, while human single-cell data provide translational context.
-
Sulfamonomethoxine (SMM): Applied Lab Workflows
2026-09-09
Build reproducible SMM assays for DHPS-linked antibacterial studies, veterinary formulation research, and environmental transformation testing. This guide prioritizes solvent control, matrix-matched comparisons, and PK-informed interpretation without transferring unrelated drug parameters.
-
Clozapine: Reliable Cell Assay Workflows
2026-09-08
This scenario-driven guide explains how Clozapine (SKU B2235) can support reproducible cell viability, proliferation, cytotoxicity, and schizophrenia research workflows. It covers solvent handling, concentration selection, hepatotoxicity study design, ERK1/2 interpretation, and practical supplier evaluation.
-
Oteseconazole: A DDI-Aware Assay Framework
2026-09-08
Oteseconazole and VT-1161 are examined through a DDI-aware framework that connects fungal CYP51 potency with transporter and human-enzyme assay interpretation. This article provides practical guidance for Candida research, resistant-strain testing, and translational decisions without confusing in vitro activity with clinical conclusions.
-
Fzd5 Links Cholesterol to Wnt Signaling in PDAC
2026-09-07
The reference study identifies Frizzled5 as a cholesterol-sensing Wnt receptor that connects lipid metabolism with receptor palmitoylation, membrane trafficking, and β-catenin signaling in pancreatic ductal adenocarcinoma. Its findings position cholesterol competition at Fzd5 as a mechanistically grounded strategy for studying Wnt-dependent tumor growth, while also defining important limits for translation beyond the tested cancer context.